Syntec Optics (OPTX) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
2 Feb, 2026Executive summary
Achieved sequential revenue growth in Q2 2024, with net sales of $7.01M, up 12% from Q1 2024, but down 8.9% year-over-year, and net income of $0.3M, a 50.4% decrease from Q2 2023.
Product sales increased 20% year-over-year to $7.0M, offsetting declines in custom tooling and engineering revenue.
Returned to positive adjusted EBITDA of $1.32M and EPS of $0.01, reversing losses from Q1 2024.
Enhanced manufacturing capabilities, implemented executive changes, and secured significant new orders in space optics, defense microdisplays, and data center connectivity.
Employee retention, relationships with industry leaders, and a strong patent portfolio are key to sustaining growth and innovation.
Financial highlights
Q2 2024 net sales were $7.01M, up 12% sequentially but down from $7.7M in Q2 2023; six months 2024 net sales were $13.3M, down 9% year-over-year.
Adjusted EBITDA for Q2 2024 was $1.32M, up from negative $0.7M in Q1 2024, but down from $1.8M in Q2 2023.
Net income for Q2 2024 was $0.3M ($0.01/share), compared to a net loss of $1.2M in Q1 2024 and net income of $0.6M in Q2 2023.
Gross profit for Q2 2024 was $2.17M, with a gross margin of 31%; six months 2024 gross margin was 22% (2023: 28%).
Cash at June 30, 2024 was $0.83M, with $3.7M unused line of credit and $4.8M equipment line of credit.
Outlook and guidance
Q3 2024 revenue expected between $9.5M and $11M, driven by growth in communications, biomedical, and defense, especially space optics and AI-related products.
Gross margin expected to remain stable or improve; general and administrative costs to rise modestly to support growth and production ramp-up.
Anticipates being net income positive in the second half of 2024, with continued strength into Q4 from communications, biomedical, and new defense product launches.
Management expects continued focus on expanding into communications and sensing end markets, leveraging advanced manufacturing and vertical integration.
Plans for bolt-on acquisitions to drive inorganic growth in the fragmented photonics industry.
Latest events from Syntec Optics
- Strong H1 2025 profit growth and margin expansion driven by defense, biomedical, and communications.OPTX
Q2 202513 Feb 2026 - Gross margin rose to 29% in H1 2025 as sales and adjusted EBITDA improved year-over-year.OPTX
Q4 202413 Feb 2026 - Q1 2025 net income turned positive on 13% sales growth and improved margins.OPTX
Q1 202513 Feb 2026 - Q3 2025 revenue rose sequentially but margins fell; liquidity improved and Q4 outlook is positive.OPTX
Q3 202512 Feb 2026 - Q3 sales up 19% year-over-year, but higher costs led to a net loss; Q4 outlook is positive.OPTX
Q3 202413 Jan 2026 - Virtual meeting to vote on directors, auditor, RSUs, and governance amendments; board recommends approval.OPTX
Proxy Filing8 Dec 2025 - Shareholders will vote on director elections, auditor ratification, and RSU grants at the virtual annual meeting.OPTX
Proxy Filing2 Dec 2025 - Shareholders will vote on directors, auditor ratification, RSU grants, and governance amendments.OPTX
Proxy Filing29 Nov 2025